Search results
Found 1080 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
CD2 corolla calls T cells to arms
General Research
21 October 2020
A team from the University of Oxford has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. The work was led by the Mike Dustin’s group at the Kennedy Institute of Rheumatology and experts in colorectal and ovarian cancers from across Oxford and computational biologists at the University of Birmingham.
Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian Community
Clinical Trials Coronavirus COVID-19 Research
21 October 2020
Europe’s BAPS Swaminarayan Sanstha is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.
New risk model estimates likelihood of hospitalisation or death from COVID-19
Coronavirus COVID-19 General Research
21 October 2020
A new risk model, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from Covid-19 has been published by The BMJ
‘Junk’ DNA could be rewiring our brains
General Research
19 October 2020
A new study by neuroscientists at the University of Oxford shows that mobile genetic elements that were active in the genomes of our ancestors could be closely linked to important functions in our brain and might help diversify our behaviour, cognition and emotions.
The transient blueprint of the brain
General Research
19 October 2020
Transient neurones match the spontaneous and sensory driven activities to shape cortical circuits: a landmark collaborative review published in Science from Professor Zoltán Molnár, Professor Patrick Kanold and Professor Heiko Luhmann.
New study reveals medium-term impact of COVID-19
Coronavirus COVID-19 General Research
19 October 2020
Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus.
Review of proposed FDA regulation reveals the extent of financial ties to industry
General Research
15 October 2020
A review of public comments on a proposed FDA regulatory framework, for modifications to artificial intelligence and machine learning-based software as a medical device, has found that 63% came from parties with financial ties to industry, and that the majority, 86% did not cite any scientific evidence.
Preventing opiod-related addiction harm after surgery
General Research
8 October 2020
An international group of experts have published guidance on how to prevent opioid-related harm in adult surgical patients.
Role-playing computer game helps players understand how vaccines work on a global scale
Coronavirus COVID-19 Public Engagement with Research Research
8 October 2020
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
Patients with cirrhosis at increased risk of death from COVID-19, study finds
Coronavirus COVID-19 General Research
7 October 2020
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19.
Hospitalised COVID-19 patients shown to be younger and healthier than flu patients
Coronavirus COVID-19 General Research
6 October 2020
Patients hospitalised with COVID-19 were more likely male, younger and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published recently by the Observational Health Data Sciences and Informatics (OHDSI) community.
Circadian rhythm: liver gene helps body keep working smoothly after late nights and midnight snacks
General Research
6 October 2020
Sites of early dysfunction in Parkinson's identified
General Research
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
New partnership with King Abdulaziz University aims to revolutionise drug discovery using artificial intelligence
General Research
1 October 2020
The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
New trial to treat Covid-19 in care homes using anti-TNF drug begins
Clinical Trials Coronavirus COVID-19 Research
30 September 2020
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
Tiny brain “tweezers” could hold the key to treat Parkinson’s
General Research
29 September 2020
A collaborative study led by Oxford Parkinson’s Disease Centre has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
Coronavirus COVID-19 Innovation Research
28 September 2020
New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.
Parkinson’s disease can affect the eyes – here’s what we know so far
General Research
28 September 2020
Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
Coronavirus COVID-19 Research
25 September 2020
Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.
Oxford’s OpenABM-Covid19 mathematical model helps UK and other countries to control the coronavirus epidemic
Coronavirus COVID-19 Research
22 September 2020